D. Boral Arc Acquisition I Corp. is a blank check company, which engages in the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2025-07-31. The firm is incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific Business Combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has no operations and has generated no revenues.
根據最新的財務報表(Form-10K),D Boral ARC Acquisition I Corp 的總資產為 $0,淨損失為 $0
BCARU 的關鍵財務比率是什麼?
D Boral ARC Acquisition I Corp 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
D Boral ARC Acquisition I Corp 的收入按細分市場或地理位置如何劃分?
D Boral ARC Acquisition I Corp 最大收入來源為 Gyre Pharmaceuticals,在最近的收益報告中收入為 105,757,000。就地區而言,China 是 D Boral ARC Acquisition I Corp 的主要市場,收入為 105,757,000。
D Boral ARC Acquisition I Corp 是否盈利?
無,根據最新的財務報表,D Boral ARC Acquisition I Corp 的淨損失為 $0